Loading...

Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine

BACKGROUND: We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were derived from a prevalent circulating recombinant form in Yunnan, China, an area of high HIV-1 incidence. The objective w...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Vasan, Sandhya, Schlesinger, Sarah J., Huang, Yaoxing, Hurley, Arlene, Lombardo, Angela, Chen, Zhiwei, Than, Soe, Adesanya, Phumla, Bunce, Catherine, Boaz, Mark, Boyle, Rosanne, Sayeed, Eddy, Clark, Lorna, Dugin, Daniel, Schmidt, Claudia, Song, Yang, Seamons, Laura, Dally, Len, Ho, Martin, Smith, Carol, Markowitz, Martin, Cox, Josephine, Gill, Dilbinder K., Gilmour, Jill, Keefer, Michael C., Fast, Patricia, Ho, David D.
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2010
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799527/
https://ncbi.nlm.nih.gov/pubmed/20111582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0008617
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!